Ricerca
971 risultati per «treatment response» — pagina 1 di 20
Le vaccinazioni nei bambini oncoematologicidurante e dopo la chemioterapia
Gruppo di Lavoro Terapia di Supporto dell’Associazione Italiana di Emato-Oncologia Pediatrica (AIEOP) — pp. 33-38
… Clin Infect Dis 2001;32:851-4. 10. Rautonen J, Siimes MA, Lundström U, et al. Vaccination of children during treatment for leukemia. Acta Paediatr Scand 1986;75: 579-85. 11. Ek T, Mellander L, Hahn-Zoric M, Abrahamsson J. Intensive treatment for childhood acute lymphoblastic leukemia reduces …
Novità in Pediatria pratica 1996-1997
F. Panizon — pp. 649-674
… factors: historical follow up by record linkage. BMJ 314, 1003, 1997. 9. Barry P: Spacer devices in the treatment of asthma. BMJ 314, 1061, 1997. 10. Tuerkas I, Demirsoy S, Koç E et al: Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor …
Il placebo, 23 anni dopo
F. Panizon, M. Fontana — pp. 571-577
… mind rather than because of its actual effect on the disease” to “improvement observed after the simulated treatment” or to “there is not only one placebo effect but there are many”. However, the “measurable” placebo effect remains a debatable and modest phenomenon. A systematic research of the …
Uso degli analoghi del GnRH nei bambini
F. Chiarelli, E. Conte — pp. 435-445
… Development Summary The development of Gonadotropin Releasing Hormone analogs (GnRHa) revolutionized the treatment of central precocious puberty (CPP). However, questions remain regarding their optimal use in CPP and other conditions in children. The European Society for Paediatric …
Novità in Pediatria pratica 1997-98
F. Panizon — pp. 661-691
… growth factor-binding protein 3 measurement. J Pediatr 131, S56, 1997. 4. Brook CGD: Views on growth hormone treatment in idiopathic shortness of stature. Acta Paediatr 87, 485, 1998. 5. Rekers-Mombarg LT, Massa GG, Matranga AMC, et al: Growth hormone therapy with three disage regimen in children …
Gestione del Covid-19 in età pediatrica: documento di consenso
Gruppo di Lavoro su Covid-19 in Pediatria della Regione Emilia-Romagna (RE-CO-PED) — pp. 85-101
… AGE: CONSENSUS DOCUMENT (Medico e Bambino 2021;40:85-) Key words Covid-19, Children, Prevention, Diagnosis, Treatment, Consensus document Summary Coronavirus disease 2019 (Covid-19) caused by SARS-CoV-2 has rapidly spread, becoming the first pandemic of the 21st century by death toll. Children …
Covid-19 e risposta immune
S. Volpi, S. Naviglio, A. Tommasini — pp. 223-231
… Lancet 2020 Mar 16 [Epub ahead of print]. 12. So LK, Lau AC, Yam LY, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003;361(9369):1615-7. 13. Ho JC, Ooi GC, Mok TY, et al. High-dose pulse versus nonpulse corticosteroid regimens in severe …
Il linfoma di Hodgkin: evoluzione del trattamento dall’osservazione dei guariti
R. Burnelli, M. Mascarin — pp. 355-364
… moglie abbiamo deciso di adottare un bambino.» Medico e Bambino 6/2017 HODGKIN’S LYMPHOMA: EVOLUTION OF TREATMENT THROUGH THE OBSERVATION OF CURED PATIENTS (Medico e Bambino 2017;36:355-364) Key words Hodgkin’s lymphoma, Long-term side effects, Chemotherapy, Radiotherapy Summary Children and …
Linfoma di Burkitt in età pediatrica
Timeus F, Piglione M, Fagioli F, Ravaglia A — pp. 175-184
… DOI: 10.1002/pbc.22047. Magrath IT. African Burkitt’s lymphoma. History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol 1991;13:222-46. Pillon M, Mussolin L, Carraro E, et al. Detection of prognostic factors in children and adolescents with Burkitt and diffuse large …
Due anni di MIS-C: peculiarità cliniche e orizzonti terapeutici
Mambelli L, Uva A, Iacono A, Del Vecchio L, Bianchedi I, Nuzzo A, Malta B, Marchetti F. — pp. 299-306
… doi: 10.53126/MEB41299) Key words Multisystem inflammatory syndrome in children, Diagnosis, Complication, Treatment Summary Introduction - MIS-C is the most relevant complication of SARS-CoV-2 infection and has an incidence of 1 case / 2,200 children and adolescents with previous infection. …
Anemia sideropenica nel III millennio“Nuovi” parametri di monitoraggio della risposta terapeutica
E. Parodi, M.L. Aurucci, B. Stella, G. Russo, U. Ramenghi — pp. 515-519
… e Bambino 8/2015 IRON DEFICIENCY ANEMIA IN THE THIRD MILLENIUM: “NEW” PARAMETERS FOR MONITORING RESPONSE TO TREATMENT (Medico e Bambino 2015;34:515-519) Key words Iron deficiency anaemia, Weaning, Dietary anamnesis, Reticulocytes, CHr Summary Iron deficiency and iron deficiency anaemia (IDA) …
Lo shock settico in età pediatrica
A. Berardi, I. Mariotti, R. Pagano, F. Scirpoli, L. Lugli, E. Garetti, M. F. Roversi, F. Ferrari — pp. 289-297
… score. Crit Care Med 1988; 16:1110-16 14. Rivers E, Nguyen B, Havstad S. Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 346:1368-77. 15. Mathur NB, Singh A, Sharma VK. Evaluation of risk factors for fatal neonatal sepsis Indian. Pediatrics …
L’inquadramento delle ipoacusie in epoca neonatale e pediatrica
A. Feresin, M. Bevacqua, G. Del Piero, P. Staffa, E. Barbi, E. Orzan — pp. 505-511
… to misdiagnosis. Conductive hearing impairment needs an accurate differential diagnosis to avoid inadequate treatments. The paper reports a case of bilateral, sensorineural hearing impairment of moderate degree in a 5-month male infant that was diagnosed after the failure of newborn hearing …
La talidomide
F. Marchetti, A. Lenhardt, M. Lazzerini, Et Al. — pp. 517-523
… lupus erythematosus, and Crohn’s disease. In the adult patient, thalidomide has been also used in the treatment of certain cancers and particularly of multiple myeloma. The most frequent side effects sonnolence, peripheral neuropathy, constipation, headaches, a maculopapular, pruritic rash. …
La varicella
P. Petaros, F. Marchetti — pp. 89-98
… HH, Kelly JM, Suarez CS, Heussner RC, Englund JA, Crane DD, McGuirt PV, Clemmer AF, Aeppli DM. Acyclovir treatment of va- ricella in otherwise healthy children. J Pediatr 1990;116(4):633-9. 50. Balfour HH, Rotbart HA, Feldman S, Dunkle LM, Feder HM, Pober CG, Hayden GF, Steinberg S, Whitley …
La carenza di ferro Parte II: Clinica, prevenzione e terapia
C. Vullo — pp. 359-374
… Summary Part II of the review on iron deficiency (ID) is devoted to clinical manifestations, prevention and treatment. Pallor and fatigue are increasingly rare as presenting signs and symptoms of ID in industrialized countries. More subtle conditions such as developmental disorders and learning …
Diarrea emorragica acuta, infezione da Escherichia coli produttori di Shiga tossine e sindrome emolitica uremica
Documento d’indirizzo inter-societario — pp. 510-518
… P, Netti GS, Santangelo L, et al. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement. Pediatr Nephrol 2019;34(3):517-27. doi: 10.1007/s00467-018-4112-2. 16. Ardissino G, Tel F, …
Gli inibitori del TNF alfa nella cura delle malattie infiammatorie croniche: luci e ombre
G. Gortani, S. Martelossi, L. Lepore — pp. 314-321
… in gastroenterology have given new hope to patients with inflammatory diseases refractory to other treatments. sentare una struttura del tutto simile a proteine normalmente presenti nell’organismo e di essere sintetizzati attraverso sofisticate (e costose) tecniche di ingegneria …
Novità in Pediatria Pratica 1998-99
F. Panizon — pp. 633-655
… BMJ 317, 1105, 1998. 11. Zorc JJ, Pusic MV, Lebet R, et al: Ipratropium bromide added to asthma treatment in the Pediatric Emergency Department. Pediatrics 103, 748, 1999. 12. Plotnick LH, Ducharne FM: Should inhaled anticholinergics be added to beta2-agonists fort treating acute …
NOVITA' IN PEDIATRIA PRATICA 2007-2008
F. Panizon — pp. 639-670
… H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008;372:1065-72. 11. Wenzel S, Wilbraham D, Fuller R, Getz EB, Longphre M. Effect of an …
Ma che fine fanno gli SGA?
G. Tornese — pp. 355-364
… e Bambino 2019;38:355-364) Key words Small for gestational age, Diagnosis, Follow-up, Growth hormone treatment Summary Recombinant human growth hormone (rhGH) is an approved and effective treatment for short children born small for gestational age (SGA). Prevalence of children eligible for …
Trattamento antibiotico di osteomielite, artrite settica e piomiosite
F. Marchetti, E. Rizzello, F. Poropat, F. Rovere, C. Germani, G. Messi, S. Demarini, M. Carbone, S. Furlan, P. Tamaro, M. Busetti, A. Ventura — pp. 585-589
… con una cefalosporina di III generazione (ceftriaxone o cefotaxime). Medico e Bambino 9/2010 ANTIBIOTIC TREATMENT FOR OSTEOMYELITIS, SEPTIC ARTHRITIS AND PYOMYOSITIS (Medico e Bambino 2010;29:585-589) Key words Osteomyelitis, Septic arthritis, Pyomyositis, Audit, Antibiotic treatment, …
La sindrome nefrosica in età pediatrica
Consensus della Società Italiana di Nefrologia Pediatrica (SINePe) — pp. 577-588
… istopatologiche, clini- Medico e Bambino 9/2019 NEPHROTIC SYNDROME IN PAEDIATRIC AGE DIAGNOSIS AND TREATMENT OF THE ONSET AND FIRST RELAPSE (Medico e Bambino 2019;38:577-588) Key words Nephrotic syndrome, Diagnosis, Treatment, Italian Paediatric Nephrology Association, Consensus …
I glucocorticoidi per via inalatoria
G. Longo — pp. 367-373
… are negligible when these indications are followed. At present, there is not clear evidence for IGCS in the treatment of acute asthma attacks. È ormai esperienza consolidata che i glucocorticoidi rappresentino il trattamento più efficace della sindrome asmatica di adulti e bambini. L’avvento …
La gestione del bambino con malattia di Kawasaki: un approccio basato sull’evidenza
G. Orso, R. Vitiello, G. Nocerino, L. De Seta — pp. 222-229
… Two atypical cases are reported. The assessment of coronary risk is based on clinical and laboratory data. Treatment with immunoglobulins (2 g/kg) reduce the risk of coronary aneurysms. In case of lack of response (10-20% of cases), a new dose of immunoglobulins should be administered. The use …
Sindrome nefrosica: raccomandazioni terapeutiche oltre le linee guida SINePe
E. Conversano, A.M.C. Galimberti, M. Bevacqua — pp. 591-595
… children. Lancet 2018;392(10141):61-74. 3. Sinha A, Saha A, Kumar M, et al. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int …
Trattare o non trattare? Il caso dell’otite media acuta
F. Marchetti — pp. 453-455
… Antibiotics, Acute otitis media, Metanalysis Summary The Author reviews the available evidence on antibiotic treatment of Acute Otitis Media (AOM) on the basis of current evidence, including two recent metanalyses. Antibiotic treatment of AOM, given the self-limited character of AOM, produces …
L'anemia falciforme
M. Lazzerini, M. Rabusin — pp. 223-234
… global scope of SCD, paediatricians need to be familiar with the knowledge of its clinical presentations and treatment. Much progress has been made during the past decades in understanding its natural history and management. This review addresses the current knowledge on SCD epidemiology, …
Difetto di attenzione- iperattività (ADHD) (Parte seconda)
G. Bartolozzi
… improvement in childre with ADHD treated with long-term methylphenidate and multimodal psycosocial treatment. J Am Acad Child Adolesc Psychiatry 2004, 43:802-11American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention …
Le molte facce della malattia infiammatoria cronica intestinale
A. Ventura e coll. — pp. 509-527
… in IBD. J Pediatr Gastroenterol Nutr 12, 411, 1991. 49. Verhave M, Winter H, Grand RJ: Azathioprine in the treatment of children with inflammatory bowel disease. J Pediatr 117, 809, 1990. 50. Feagan B, Rochon J, Fedorak R, et al: Methotrexate for treatment of Crohn disease. N Engl J Med 332, …
Lo shock settico nei primi tre mesi di vita
Crestani S, Passini E, Spaggiari V, Toffoli C, Boncompagni A, Bedetti L, Spaggiari E, Lucaccioni L, Lugli L, Roversi F, Rossi K, Iughetti L, Berardi A. — pp. 567-575
… e Bambino 2021;40(9):567-575. doi: 10.53126/MEB40567) Key words Septic shock, Sepsis, Newborn, Infant, Treatment Summary Shock is a generalized tissue hypoperfusion that leads to severe cellular distress and complicates some cases of paediatric and neonatal sepsis. Although a reduction in …
L'ipertensione arteriosa in età pediatrica: dall'inquadramento diagnostico alla terapia
A. de Cunto, M. Maschio, M. Pennesi, A. Benettoni — pp. 226-234
… in termini di aumento 226 MANAGEMENT OF HYPERTENSION IN CHILDREN AND ADOLESCENTS: FROM DIAGNOSIS TO TREATMENT (Medico e Bambino 2008;27:226-234) Key words Hypertension, Antihypertensive drugs, Obesity, Hypertensive emergencies, Left ventricular hypertrophy Summary The epidemic of …
L'esofagite eosinofila
J. Bua, F. Marchetti, I. Giuseppin, M. Marani, V. Villanacci, E. Barbi, S. Martelossi, A. Ventura — pp. 500-508
… EE clinical presentation in children, how to diagnose it and what is the evidence supporting its available treatment options. They also report their clinical experience of 8 new EE cases diagnosed during a 3 year-period. vello della lamina propria di stomaco, intestino tenue, colon, in …
Nuovi usi per vecchi farmaci nelle malattie autoimmuni
L. Lepore e coll. — pp. 368-370
… Clin Exp Immunolol 110, 151, 1997. 2. Jacobson JM, Greenspan JS, Spritzler J, et al: Thalidomide for the treatment of oral aphthous ulcers in pazients with human immunodeficiency virus infection. N Engl J Med 336, 1487, 1997. 3. Hamuryudan V, Mat C, Saip S, et al: Thalidomide in the treatment …
Malattia di Kawasaki: quale dose di immunoglobuline nei bambini grandi?
L. Mambelli, A. Iacono, G. Rametta, F. Marchetti — pp. 231-233
… aneurysms, intravenous immunoglobulin (IVIg) resistance, duration of the hospitalisation and adverse treatment effects among the groups treated with 2 g/kg and 1 g/kg doses of IVIg. New randomised controlled studies are desirable to check the most appropriate IVIg dose for old children, …
La pediatria sulla grande stampa 2016
Alessandro Ventura
Clinica Pediatrica, IRCCS Burlo Garofolo, Università di Trieste
— pp. 1611-1611
… safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet 2016;387(10013):40-52). Non si sono registrati effetti collaterali maggiori. Una vera pallottola magica, …
La pediatria sulla grande stampa 2016
Alessandro Ventura
Clinica Pediatrica, IRCCS Burlo Garofolo, Università di Trieste
— pp. 1611-1611
… safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet 2016;387(10013):40-52). Non si sono registrati effetti collaterali maggiori. Una vera pallottola magica, …
Quando l’asma è “difficile”: il ruolo dell’omalizumab
G. Vieni, L. Biserna, F. Marchetti — pp. 177-181
… per pollini di graminacee (13 mm ++++), acari della polvere (5 Medico e Bambino 3/2017 SEVERE ASTHMA: TREATMENT WITH OMALIZUMAB (Medico e Bambino 2017;36:177-181) Key words Asthma, Omalizumab, Severe asthma, Anti-IgE effect, Children Summary The percentage of asthmatic children with severe …
Dal bambino linfatico al bambino con infezioni respiratorie ricorrenti
F. Panizon — pp. 183-189
… Medico e Bambino 2003;22:441. 21. Olympia RP, Khine H, Avner JR. Effectiveness of oral dexamethasone in the treatment of moderate to severe pharyngitis in children. Arch Pediatr Adolesc Med 2005;115:280. Sinusite 22. Barbi E, Longo G. La sinusite. Medico e Bambino 2001;20:612. 23. Battistini A, …
Guida pratica per il bambino con sindrome di Prader-Willi
G. Tornese, S. Pastore, G. Tonini
… J Pediatr Endocrinol Metab 2001;14:1097-105. Lindgren AC, Hellström LG, Ritzén EM, Milerad J. Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur J Pediatr 1999;158:936-40. Haqq AM, Stadler DD, Jackson RH, …
Diagnosi di malattia di Pompe nel neonato
C. Amador, M. Sacchini, E. Agostini, E. Procopio, E. Laudani, P. Fiorini
… J Pediatr 2004;144:S35-43. Pascual SI. Phenotype variations in early onset Pompe disease: diagnosis and treatment results with Myozyme. Adv Exp Med Biol 2009;652:39-46. Pellegrini N, Laforet P, Orlikowski D, et al. Respiratory insufficiency and limb muscle weakness in adults with Pompe's …
Indicazioni alla splenectomia
P. Tamaro, E. Barth — pp. 373-375
… and in providing immunologic response to encapsulated bacteria. Surgical splenectomy provides effective treatment for several paediatric disorders, such as congenital and acquired haemolytic anemias, abdominal traumas, immunologic and metabolic disorders, but it is associated with immediate …
Aplasie midollari acquisite in età pediatrica: raccomandazioni diagnostico-terapeutiche
Gruppo di Lavoro “Insufficienze Midollari” dell’AIEOP — pp. 383-389
… supportive care. In SAA haematopoietic stem cell transplant (HSCT) from a matched sibling donor (MSD) is the treatment of choice. If a MSD is not available, the options include immunosuppressive therapy (IST) or unrelated donor HSCT. The objective of this guideline is to provide healthcare …
Disordini demielinizzanti nel bambino e nell’adolescente: ADEM, neurite ottica e MOGAD
Dal Bo S, Ruscelli M, Cenni P, Piscaglia MG, D’Eliseo D, Marchetti F. — pp. 231-236
… syndromes such as ADEM, optic neuritis, transverse myelitis, and AQP4-seronegative NMOSD. The first-line of treatment commonly recognized in the acute phase is IV corticosteroids in high-dose or IV immunoglobulins. In case of relapse, the drug with evidence of efficacy is rituximab; other choices …
Malattia grassa del fegato: tra fattori ambientali e predisposizione genetica
Mosca A, Maggiore G. — pp. 355-362
… 2. Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology …
Le citochine: da mediatori della flogosi a bersaglio della terapia
T. Not, E. Buratti, I. Berti, C. Trevisiol, E. Neri, A. Tommasini — pp. 103-107
… JAMA 277, 1531-1538, 1997. 23. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM et al: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 337, 141-147, 1997. 24. Targan SR, Hanauer SB et al: A …
Reticolociti: un parametro poco conosciuto e troppo poco utilizzato
U. Ramenghi, G. Ansaldi, M. Davitto, A. Mondino, C. Olivieri, R. Mazzone — pp. 649-651
… is particularly useful to diagnose haemolityc anaemias that show high count and to evaluate the response to treatment of patients with iron-deficiency-anaemia. gravidanza). In condizioni patologiche, i livelli sono molto differenti dalla normalità. La percentuale dell’1%, spesso riportata come …
Epilessia con mioclonie palpebrali e assenze
L. Marangio, E. Fiumana, G. La Fauci, R. Faggioli
… Verrotti A, Tocco AM, Salladini C, Latini G, Chiarelli F. Human photosensitivity: from pathophysiology to treatment. European Journal of Neurology 2005;12: 828–4. Panayiotopoulos CP. Reflex seizure and reflex epilepsies. In: Panayiotopoulos CP. A clinical guide to epileptic syndromes and their …
L’ipoglicemia da iperinsulinismo: la diagnosi, le cause, la gestione
F. Marchetti, V. Graziani, M. Cappella, G. Vieni, C. Muratori, T. Tosi, M. La Bianca, F. Faletra — pp. 309-314
… analysis confirmed a mutation of GLUD1, encoding glutamate dehydrogenase. Clinical response to diazoxide treatment was optimal with normal fasting blood glucose levels. Congenital hyperinsulinaemic hypoglicaemia (CHH) represents a group of clinically, genetically and morphologically …
Stiff-Baby Syndrome: quando pensarci. Il caso di Sofia
P. Assandro, C. Sanesi, C. Trevisol, L. Travan
… quadriparesis or epilepsy, therefore it should be promptly identified during the neonatal period. Its treatment with benzodiazepines alleviates the debilitating symptoms, may prevent life-threatening events and enables better feeding and handling. The disorder is mainly due to hereditary …